Concepedia

Kenneth W. Bair

KW

Statistics

Publications

44

Citations

3.6K

H-Index

30

Active since

1972

Affiliations

Forma Therapeutics (United States)(Current)

Novartis (Switzerland)

Novartis (United States)

Burroughs Wellcome Fund

University of California, Santa Cruz

Kenneth W. Bair is an author at Forma Therapeutics (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1972–2019

44

Publications

44

Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway

Andrew L. Kung, Sonya Zabludoff, Dennis S. France et al. · Cancer Cell · 2004 · 478 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Molecular basis of USP7 inhibition by selective small-molecule inhibitors

A.P. Turnbull, Stephanos Ioannidis, Wojciech Krajewski et al. · Nature · 2017 · 468 citations

Medicine, Molecular Biology, Pharmacology +14

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

Ying-Nan P. Chen, Sushil Sharma, Timothy M. Ramsey et al. · Proceedings of the National Academy of Sciences · 1999 · 319 citations

Life Sciences, Cancer Biology, Oncology +17

Psammaplins from the Sponge <i>Pseudoceratina </i><i>p</i><i>urpurea:</i> Inhibition of Both Histone Deacetylase and DNA Methyltransferase

Ivette C. Piña, Jeffrey T. Gautschi, Gui-Yang-Sheng Wang et al. · The Journal of Organic Chemistry · 2003 · 310 citations

Life Sciences, Biochemistry, Marine Biology +17

Proteomics-based Target Identification

Harry Towbin, Kenneth W. Bair, James A. DeCaprio et al. · Journal of Biological Chemistry · 2003 · 144 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 44